Patent directory · USPTO A61K / A61P
Patents matching “BicycleRD Limited”
23 pharma patents match "BicycleRD Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 23 pharmaceutical patents matching "BicycleRD Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12377155
Bicyclic peptide ligands specific for PSMA
granted -
US 12318454
Bicyclic peptide ligands specific for MT1-MMP
granted -
US 11912794
Modulation of structured polypeptide specificity
granted -
US 11814447
Peptide ligands for binding to EphA2
granted -
US 11753444
Modulation of structured polypeptide specificity
granted -
US 11746126
Bicyclic peptide ligands with detectable moieties and uses thereof
granted -
US 11672868
Bicyclic peptide ligands specific for MT1-MMP
granted -
US 11623012
Bicyclic peptide ligands specific for EphA2
granted -
US 11433137
Compounds for treating cancer
granted -
US 11414488
Methods for treating cancer
granted -
US 11103591
Bicyclic peptide ligands specific for MT1-MMP
granted -
US 10994019
Bicyclic peptide-toxin conjugates specific for MT1-MMP
granted -
US 10899798
Bicyclic peptide ligands with detectable moieties and uses thereof
granted -
US 10894808
Polypeptide ligands specific for plasma kallikrein
granted -
US 10870679
Modulation of structured polypeptide specificity
granted -
US 10800813
Modulation of structured polypeptide specificity
granted -
US 10792368
Bicyclic peptide ligands specific for MT1-MMP
granted -
US 10624968
Compounds for treating cancer
granted -
US 10532106
Bicyclic peptide ligands specific for MT1-MMP
granted -
US 10441663
Methods for treating cancer
granted -
US 10294274
Polypeptide ligands specific for plasma kallikrein
granted -
US 10118947
Modulation of structured polypeptide specificity
granted -
US 9994617
Modulation of structured polypeptide specificity
granted